161 related articles for article (PubMed ID: 12141065)
1. Biomonitoring of tobacco smoke carcinogenicity by dosimetry of DNA adducts and genotyping and phenotyping of biotransformational enzymes: a review on polycyclic aromatic hydrocarbons.
Besaratinia A; Kleinjans JC; Van Schooten FJ
Biomarkers; 2002; 7(3):209-29. PubMed ID: 12141065
[TBL] [Abstract][Full Text] [Related]
2. DNA adducts of aromatic amines present in tobacco smoke.
Marques MM; Beland FA
IARC Sci Publ; 1994; (125):453-6. PubMed ID: 7806338
[No Abstract] [Full Text] [Related]
3. Putative susceptibility markers of coronary artery disease: association between VDR genotype, smoking, and aromatic DNA adduct levels in human right atrial tissue.
Van Schooten FJ; Hirvonen A; Maas LM; De Mol BA; Kleinjans JC; Bell DA; Durrer JD
FASEB J; 1998 Oct; 12(13):1409-17. PubMed ID: 9761785
[TBL] [Abstract][Full Text] [Related]
4. Bioactivation of polycyclic aromatic hydrocarbon carcinogens within the vascular wall: implications for human atherogenesis.
Ramos KS; Moorthy B
Drug Metab Rev; 2005; 37(4):595-610. PubMed ID: 16393887
[TBL] [Abstract][Full Text] [Related]
5. Genetic polymorphism of CYP genes, alone or in combination, as a risk modifier of tobacco-related cancers.
Bartsch H; Nair U; Risch A; Rojas M; Wikman H; Alexandrov K
Cancer Epidemiol Biomarkers Prev; 2000 Jan; 9(1):3-28. PubMed ID: 10667460
[TBL] [Abstract][Full Text] [Related]
6. Biomarkers of genotoxicity of air pollution (the AULIS project): bulky DNA adducts in subjects with moderate to low exposures to airborne polycyclic aromatic hydrocarbons and their relationship to environmental tobacco smoke and other parameters.
Georgiadis P; Topinka J; Stoikidou M; Kaila S; Gioka M; Katsouyanni K; Sram R; Autrup H; Kyrtopoulos SA;
Carcinogenesis; 2001 Sep; 22(9):1447-57. PubMed ID: 11532867
[TBL] [Abstract][Full Text] [Related]
7. Metabolic polymorphism affecting DNA binding and excretion of carcinogens in humans.
Bartsch H; Rojas M; Alexandrov K; Camus AM; Castegnaro M; Malaveille C; Anttila S; Hirvonen K; Husgafvel-Pursiainen K; Hietanen E
Pharmacogenetics; 1995; 5 Spec No():S84-90. PubMed ID: 7581496
[TBL] [Abstract][Full Text] [Related]
8. [Metabolic polymorphisms and biomarkers of exposition to polycyclic aromatic hydrocarbons (PAH)].
Szczeklik J
Przegl Lek; 2005; 62(12):1542-5. PubMed ID: 16786792
[TBL] [Abstract][Full Text] [Related]
9. [Carcinogenic effect of tobacco smoke].
Starek A; Podolak I
Rocz Panstw Zakl Hig; 2009; 60(4):299-310. PubMed ID: 20361554
[TBL] [Abstract][Full Text] [Related]
10. Carcinogen: DNA adducts in tobacco smoke-associated cancer of the upper respiratory tract.
Szyfter K; Banaszewski J; Jałoszyński P; Pabiszczak M; Szyfter W; Szmeja Z
Acta Biochim Pol; 1999; 46(2):275-87. PubMed ID: 10547029
[TBL] [Abstract][Full Text] [Related]
11. Synergistic mechanisms in carcinogenesis by polycyclic aromatic hydrocarbons and by tobacco smoke: a bio-historical perspective with updates.
Rubin H
Carcinogenesis; 2001 Dec; 22(12):1903-30. PubMed ID: 11751421
[TBL] [Abstract][Full Text] [Related]
12. Metabolic genetic polymorphisms and susceptibility to lung cancer.
Bouchardy C; Benhamou S; Jourenkova N; Dayer P; Hirvonen A
Lung Cancer; 2001 May; 32(2):109-12. PubMed ID: 11325480
[TBL] [Abstract][Full Text] [Related]
13. Applicability of induced sputum for molecular dosimetry of exposure to inhalatory carcinogens: 32P-postlabeling of lipophilic DNA adducts in smokers and nonsmokers.
Besaratinia A; Maas LM; Van Breda SG; Curfs DM; Kleinjans JC; Wouters EF; Van Schooten FJ
Cancer Epidemiol Biomarkers Prev; 2000 Apr; 9(4):367-72. PubMed ID: 10794480
[TBL] [Abstract][Full Text] [Related]
14. DNA adducts produced by oils, oil fractions and polycyclic aromatic hydrocarbons in relation to repair processes and skin carcinogenesis.
Ingram AJ; Phillips JC; Davies S
J Appl Toxicol; 2000; 20(3):165-74. PubMed ID: 10797468
[TBL] [Abstract][Full Text] [Related]
15. Formation of stable DNA adducts and apurinic sites upon metabolic activation of bay and fjord region polycyclic aromatic hydrocarbons in human cell cultures.
Melendez-Colon VJ; Luch A; Seidel A; Baird WM
Chem Res Toxicol; 2000 Jan; 13(1):10-7. PubMed ID: 10649961
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of the formation of benzo[a]pyrene adducts to DNA in A549 lung cells exposed to mixtures of polycyclic aromatic hydrocarbons.
Genies C; Jullien A; Lefebvre E; Revol M; Maitre A; Douki T
Toxicol In Vitro; 2016 Sep; 35():1-10. PubMed ID: 27196671
[TBL] [Abstract][Full Text] [Related]
17. Carcinogenicity of polycyclic aromatic hydrocarbons.
Straif K; Baan R; Grosse Y; Secretan B; El Ghissassi F; Cogliano V;
Lancet Oncol; 2005 Dec; 6(12):931-2. PubMed ID: 16353404
[No Abstract] [Full Text] [Related]
18. Mechanistic linkage between DNA adducts, mutations in oncogenes and tumorigenesis of carcinogenic environmental polycyclic aromatic hydrocarbons in strain A/J mice.
Nesnow S; Ross JA; Stoner GD; Mass MJ
Toxicology; 1995 Dec; 105(2-3):403-13. PubMed ID: 8571376
[TBL] [Abstract][Full Text] [Related]
19. Cytochrome P4501A2: enzyme induction and genetic control in determining 4-aminobiphenyl-hemoglobin adduct levels.
Landi MT; Zocchetti C; Bernucci I; Kadlubar FF; Tannenbaum S; Skipper P; Bartsch H; Malaveille C; Shields P; Caporaso NE; Vineis P
Cancer Epidemiol Biomarkers Prev; 1996 Sep; 5(9):693-8. PubMed ID: 8877060
[TBL] [Abstract][Full Text] [Related]
20. 32P-postlabelling of aromatic DNA adducts in white blood cells and alveolar macrophages of smokers: saturation at high exposures.
Van Schooten FJ; Godschalk RW; Breedijk A; Maas LM; Kriek E; Sakai H; Wigbout G; Baas P; Van't Veer L; Van Zandwijk N
Mutat Res; 1997 Aug; 378(1-2):65-75. PubMed ID: 9288886
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
